Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Gastrointestinal Cancer Research : GCR|November 1, 2012
The expanding role of somatostatin analogs in the management of neuroendocrine tumorsEdward M WolinThe Oncologist|August 27, 2015
Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future ConsiderationsEdward M WolinCancer Letters|February 20, 2013
PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumorsEdward M WolinChemotherapy|March 14, 2015
Long-term everolimus treatment of patients with pancreatic neuroendocrine tumorsEdward M WolinSurgical Oncology Clinics of North America|September 20, 2017
Randomized Controlled Trials in Neuroendocrine TumorsJohn C McAuliffe, Edward M WolinOncology|April 25, 2019
Systemic Treatment Options for Carcinoid Syndrome: A Systematic ReviewEdward M Wolin, Al Bowen Benson IiiPancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six casesAnna Milanesi, Run Yu, Edward M WolinPancreas|April 11, 2022
Resection Prolongs Overall Survival for Nonmetastatic Midgut Small Bowel Neuroendocrine Tumors: A National Cancer Data Base StudyVenu Gopal Bangla, Edward M Wolin, Michelle Kang Kim, et al.Cancer Chemotherapy and Pharmacology|June 15, 2013
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I studyEdward M Wolin, Ke Hu, Gareth Hughes, et al.Pageof 5